Maule Stem Cell Research Institute
Company
Maule Stem Cell Research Institute develops one asset, in phase 1 (Matrix in interstitial lung disease). Mostly other.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 1
- Signal
Pipeline
1Phase 1, Other, interstitial lung disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals2
- Similar companies6